Comparison of holmium laser enucleation and transurethral resection of prostate in benign prostatic hyperplasia: a systematic review and meta-analysis.
Chen F, Chen Y, Zou Y, Wang Y, Wu X, Chen M.
J Int Med Res. 2023 Aug;51(8):3000605231190763. doi: 10.1177/03000605231190763.
Holmium laser enucleation of the prostate (HoLEP): a review and update.
Das AK, Teplitsky S, Humphreys MR.
Can J Urol. 2019 Aug;26(4 Suppl 1):13-19.
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023.
Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, Wilt TJ.
J Urol. 2024 Jan;211(1):11-19. doi: 10.1097/JU.0000000000003698. Epub 2023 Sep 14.
Simulation training in transurethral resection/laser vaporization of the prostate; evidence from a systematic review by the European Section of Uro-Technology.
Tokas T, Ortner G, Peteinaris A, Somani BK, Herrmann T, Nagele U, Veneziano D, Gözen AS, Kallidonis P.
World J Urol. 2022 May;40(5):1091-1110. doi: 10.1007/s00345-021-03886-0. Epub 2021 Nov 20.
Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
Nguyen DD, Li T, Ferreira R, Baker Berjaoui M, Nguyen AV, Chughtai B, Zorn KC, Bhojani N, Elterman D.
Prostate Cancer Prostatic Dis. 2024 Mar;27(1):22-28. doi: 10.1038/s41391-023-00669-z. Epub 2023 Apr 20.
HoLEP: the new gold standard for surgical treatment of benign prostatic hyperplasia.
Shvero A, Calio B, Humphreys MR, Das AK.
Can J Urol. 2021 Aug;28(S2):6-10.
A systematic review and meta-analysis of efficacy and safety comparing greenlight laser vaporization with transurethral resection of the prostate for benign prostatic hyperplasia with prostate volume less than 80 ml.
Liu S, Liu H, Yao H, Sun F, Wu J, Zhou Z.
Lasers Med Sci. 2023 Jun 8;38(1):133. doi: 10.1007/s10103-023-03794-2.
GreenLight laser vaporization of the prostate: has it come of age?
Gomez-Sancha F.
Curr Opin Urol. 2015 Jan;25(1):40-4. doi: 10.1097/MOU.0000000000000124.
Vaporization of the prostate.
McAllister WJ, Gilling PJ.
Curr Opin Urol. 2004 Jan;14(1):31-4. doi: 10.1097/00042307-200401000-00007.
Efficacy and safety of Vibegron for the treatment of residual overactive bladder symptoms after laser vaporization of the prostate: A single-center prospective randomized controlled trial (VAPOR TRIAL).
Seki N, Masaoka H, Song Y, Dejima T, Sato Y, Maeda S.
Low Urin Tract Symptoms. 2024 Jul;16(4):e12529. doi: 10.1111/luts.12529.
